Report: India eyes penalties for Johnson & Johnson over metal-on-metal hips

Johnson & Johnson (NYSE:JNJ) could reportedly be on the hook again for the metal-on-metal hip implants it pulled from the market in 2010, this time in India and for much less than it’s cost the company elsewhere. The world’s second-largest medical device maker has fielded numerous lawsuits about its ASR metal-on-metal hip replacement since it pulled the ASR XL Acetabular and ASR Hip Resurfacing systems from the market in August 2010, “due to the number of patients who required a second hip replacement procedure, called a revision surgery.” Three years later Johnson & Johnson pulled the plug on metal-on-metal hip implants altogether. Last week a Dallas federal jury ruled that Johnson & Johnson and its DePuy Orthopaedics subsidiary must pay $247 million to six patients implanted with its Pinnacle MoM implants. Four years ago the company agreed to a $2.5 billion settlement with 8,000 plaintiffs implanted with its DePuy ASR device. According to an Indian media report, an 11-member health ministry committee there found in February that J&J was guilty of “serious medical negligence” in at least 22 of the 101 cases the panel investigated. The ruling means the company could be fined some $676,000 (r44.0 million), or about $30,700 (r20 million) per patient, according to a pair of anonymous panel members cited by LiveMint.com. Those 22 cases involved at least one revision surgery and, in some cases, a third surgical procedu...
Source: Mass Device - Category: Medical Devices Authors: Tags: Legal News Metal-on-Metal johnsonandjohnson Source Type: news